Lung Cancer Screening Based on Type-different Sensor Arrays
暂无分享,去创建一个
Wang Li | Hongying Liu | Zichun He | Hongying Liu | Wang Li | Hongying Liu | Xititan Pi | Dandan Xie | Xititan Pi | Zichun He | Dandan Xie
[1] Q. Jöbsis,et al. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review , 2012, Respiratory Research.
[2] L. Qiu,et al. A preliminary study , 2018, Medicine.
[3] S. Papper,et al. HYPERKALEMIA AND HYPOKALEMIA. , 1964, Disease-a-month : DM.
[4] H. Haick,et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.
[5] Tarek Mekhail,et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.
[6] H. J. O’neill,et al. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. , 1988, Clinical chemistry.
[7] Julian King,et al. Stability of selected volatile breath constituents in Tedlar, Kynar and Flexfilm sampling bags. , 2013, The Analyst.
[8] M. Fiegl,et al. Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.
[9] O. Fontes. [Hepatic coma]. , 1959, Arquivos brasileiros de medicina.
[10] Haishan Zeng,et al. A Raman cell based on hollow core photonic crystal fiber for human breath analysis. , 2014, Medical physics.
[11] N. Ratcliffe,et al. The importance of methane breath testing: a review , 2013, Journal of breath research.
[12] J. Skosey,et al. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. , 1988, Free radical research communications.
[13] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[14] G. Sun,et al. Quantitative breath analysis of volatile organic compounds of lung cancer patients. , 2010, Lung cancer.
[15] M. Phillips,et al. Increased pentane and carbon disulfide in the breath of patients with schizophrenia. , 1993, Journal of clinical pathology.
[16] Ricardo Gutierrez-Osuna,et al. The how and why of electronic noses , 1998 .
[17] M. Ledochowski,et al. Implementation and interpretation of hydrogen breath tests , 2008, Journal of breath research.
[18] M. Phillips,et al. Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[19] H. Haick,et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.
[20] B. Buszewski,et al. Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. , 2009, Biomedical chromatography : BMC.
[21] C. Olopade,et al. Exhaled pentane levels in acute asthma. , 1997, Chest.
[22] A. Diehl,et al. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis , 2001, American Journal of Gastroenterology.
[23] G. Hanna,et al. Exhaled breath acetone for therapeutic monitoring in pneumonia using selected ion flow tube mass spectrometry (SIFT-MS) , 2013 .
[24] Terence H Risby,et al. Breath biomarkers for detection of human liver diseases: preliminary study , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[25] Silvia Conforto,et al. Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD , 2013, Journal of breath research.
[26] S. Cunnane,et al. Epilepsy and the Ketogenic Diet: Assessment of Ketosis in Children Using Breath Acetone , 2002, Pediatric Research.
[27] Sara Salehi,et al. Highly sensitive carbon nanotubes–SnO2 nanocomposite sensor for acetone detection in diabetes mellitus breath , 2014 .
[28] H. Zeng,et al. A comparison of spectroscopic techniques for human breath analysis , 2012 .
[29] Raed A Dweik,et al. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[30] Bogusław Buszewski,et al. Analysis of exhaled breath for disease detection. , 2014, Annual review of analytical chemistry.
[31] David Smith,et al. Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis. , 2014, Bioanalysis.
[32] H. J. O’neill,et al. Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.
[33] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[34] R. Fall,et al. Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. , 2001, Journal of applied physiology.
[35] P. Mazzone,et al. Exhaled breath volatile organic compound biomarkers in lung cancer , 2012, Journal of breath research.
[36] Eugenio Martinelli,et al. Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease. , 2016, Current topics in medicinal chemistry.
[37] I. Hirata,et al. Breath and blood ammonia in liver cirrhosis. , 2000, Hepato-gastroenterology.
[38] P. Španěl,et al. Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. , 1997, Kidney international.
[39] W. Miekisch,et al. Breath gas aldehydes as biomarkers of lung cancer , 2009, International journal of cancer.
[40] Robert C. Wolpert,et al. A Review of the , 1985 .
[41] J. Orens,et al. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[42] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[43] D. Kavanagh,et al. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? , 2009, BMC Cancer.
[44] R. Dweik,et al. Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study , 2015, Clinical and Translational Gastroenterology.
[45] L. Bianchi,et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.
[46] Paolo Montuschi,et al. The Electronic Nose in Respiratory Medicine , 2012, Respiration.
[47] Sorin Draghici,et al. Machine Learning and Its Applications to Biology , 2007, PLoS Comput. Biol..
[48] K. Shirato,et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. , 2000, American journal of respiratory and critical care medicine.
[49] K. Garey,et al. Collection and analysis of exhaled breath condensate in humans. , 2001, American journal of respiratory and critical care medicine.
[50] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[51] H L Wang,et al. Relationship between sulcular sulfide level and oral malodor in subjects with periodontal disease. , 2001, Journal of periodontology.
[52] Olaf Tietje,et al. Volatile biomarkers of pulmonary tuberculosis in the breath. , 2007, Tuberculosis.
[53] Tarek Mekhail,et al. Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[54] S. Nair,et al. Obesity and female gender increase breath ethanol: Potential implications for the pathogenesis of nonalcoholic steatohepatitis , 2000 .